Reuters logo
BRIEF-Rexahn Pharmaceuticals announces $10 mln registered direct offering
2017年6月7日 / 下午1点33分 / 5 个月前

BRIEF-Rexahn Pharmaceuticals announces $10 mln registered direct offering

June 7 (Reuters) - Rexahn Pharmaceuticals Inc

* Rexahn announces $10 million registered direct offering

* Rexahn Pharmaceuticals Inc - net proceeds of offering will be used for further development of rexahn’s lead clinical programs,

* Rexahn Pharmaceuticals - entered agreements to purchase about 3.03 million shares of stock and warrants exercisable for up to about 1.52 million shares of stock Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below